Last updated: May 7, 2024
Sponsor: Universiti Sains Malaysia
Overall Status: Active - Recruiting
Phase
N/A
Condition
Glaucoma
Treatment
Control group
Green tean group
Clinical Study ID
NCT06235827
RSCH ID-23-03868-NIT
Ages 18-80 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Patient with confirmed diagnosis of primary glaucoma (POAG/PACG/NTG) that achievetarget IOP with medical therapy at least for 6 months.
- Never consume green tea as daily drinks.
Exclusion
Exclusion Criteria:
- Dense cataract with Lens Opacity Classification Sytem (LOCS II) of more than grade 2
- Any other ocular media opacity that may interfere with OCT imaging ( eg: corneascar/vitreous haemorrhage)
- Any history of optic neuropathy
- History of glaucoma or retinal surgery
- Macular degeneration and retinal disorder
- Patient with caffein sensitive that causes unpleasant reaction (eg: palpitation,insomnia, nausea, constipation)
- Allergic to green tea
Study Design
Total Participants: 100
Treatment Group(s): 2
Primary Treatment: Control group
Phase:
Study Start date:
February 01, 2024
Estimated Completion Date:
June 30, 2025
Study Description
Connect with a study center
Hospital Universiti Sains Malaysia
Kubang Kerian, Kelantan 16150
MalaysiaActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.